Skip Navigation and Go To Content
Jaroslaw (Jarek) Aronowski, MD, PhD

Jaroslaw (Jarek) Aronowski, MD, PhD

Professor, Department of Neurology
Vice Chair for Research, Department of Neurology
Roy M. and Phyllis Gough Huffington Chair in Neurology
Director of Stroke Research

Jaroslaw (Jarek) Aronowski, MD, PhD
713-500-7059713-500-7059

National Services:

  • 2001 – 2006 – Member of the National Institute of Health Grant Review Study Section – Brain Disorders and Clinical Neuroscience 1 (BDCN-1/CND)
  • October 2003 – Invited Participant -NIH-NINDS – Priorities for Clinical Research in the Treatment of Acute, non-Traumatic Intracerebral Hemorrhage Workshop, 2003. The panel was established to create new guidelines for research in ICH treatment
  • November 2003 – Invited speaker, NIH-NINDS Stroke Conference
  • 2004 – 2009 – Brain 2 – American Heart Association- grant review panel (co-chairman of the study group)
  • November 2005 – NINDS Special Emphasis Panel ZNS1 SRB-M Study Section
  • 2005 – Advisory Board member for the 1st International Symposium on Cerebral Hemorrhage. Ann Arbor, Michigan
  • November 2006 – Planning Committee member – NIH, NINDS Workshop on Models of Geriatric Epilepsy
  • April 2006 – Loan Repayment Program NIH Study Sections – 2006/08 ZNS1 SRB-M (35)
  • 2006 – Present – Fellowship (F30) NIH-NINDS Study Section – 2006/08 ZNS1 SRB-M (36)
  • 2006 – Stroke Progress Review Group (SPRG) – Topic – Intracerebral Hemorrhage advisory panel – NIH, NINDS. The panel was established to create new research and clinical recommendations to NIH
  • November 2006 – Fellowship (F30/F05) NIH-NINDS grant review study section – 2007/01 ZNS1 SRB-M (39)
  • 2007 – Advisory Board Member for the 2nd International Symposium on Cerebral Hemorrhage
  • 2007 – Organizing Committee, 26th Princeton Conference on Cerebrovascular Disease, Houston, Texas
  • March 2008 – NIH/NINDS – Special Emphasis Panel/Scientific Review 2008/05 ZNS1 SRB-M (57)
  • September 2008 NIH 10 ZRG1 BDCN-N (93) S Neurodegenerative Disorders and Injury
  • October 2008 – present, NIH, NINDS, Charter Member – Neurological Sciences Training Initial Review Group, NST-2 (F30 and K99 awards)
  • June 2009 – NIH – RFA-OD-09-003 Challenge Grant Panel 11
  • October 2009 – NIH – Acute Neural Injury and Epilepsy Study Section (ANIE) Brain Disorders and Clinical Neuroscience Integrated Review Group
  • February 2010 – Invited Moderator of a session on “Hemorrhage – Intraparenchymal” – International Stroke Conference, San Antonio, Texas
  • March 2010 – Invited Chairman of the session on Hematoma Resolution – International Intracerebral Hemorrhage Conference, Palm Springs, CA
  • April 2010 – Invited Speaker at 27th Princeton Conferences on Cerebrovascular Disease, Boston, MA
  • July 2010 – Invited lectures at the symposium “Nuclear receptors”; WorldPharma2010, Copenhagen, Denmark
  • March 2011 – Invited lectures at the 2nd Venusberg Meeting on Neuroinflammation. Bonn. Germany.
  • June 2011 – NIH – Acute Neural Injury and Epilepsy Study Section (ANIE) Brain Disorders and Clinical Neuroscience Integrated Review Group
  • 2011 – NIH, NINDS. Stroke Progress Review Group (SPRG) – Topic – Intracerebral Hemorrhage advisory panel –The panel was established to create new research and clinical recommendations to NIH. Co-Chairman of the panel.
  • 2011 – 2015, Board of Directors of the International Society for Cerebral Blood Flow and Metabolism (ISCBFM).
  • August 2012 – Member of Planning Group to Establish NIH Future Goals/Priorities in Stroke Research – NIH, NINDS. Stroke Progress Review Group (SPRG), Bethesda.
  • September 2012, NIH. ZRG1 BDCN-W 02, Brain Disorders and Clinical Neuroscience Integrated Review Group
  •  August 2012 – Gordon Research Conference — Brain Energy Metabolism and Blood Flow – Chairman of the “Neuroinflammation” session
  • November, 2012 – NIH-NINDS Neurological Sciences and Disorders K (NSD-K) review panel and ZNS1 SRB-G (62) PHASE III CLINICAL TRIALS
  • April 2013 – NIH- Special Emphasis Panel/Scientific Review Group 2013/05 ZNS1 SRB-G (65)
  • June 2013. NIH – ZRG1 BDCN-N (55) RPAR Panel: Brain Disorders in the Developing World Research Across the Lifespan
  • November 2013. NIH-NINDS Neurological Sciences and Disorders K (NSD-K) review panel. PHASE III CLINICAL TRIALS
  • November, 2013 – 2 NIH-NINDS 014/01 ZNS1 SRB-G (73); NEURONEXTEXT SEP – review committee
  • June 2014. NIH (CSR) – Brain Injury and Neurovascular Pathologies Study Section (BINP) – review committee

Education & Training

Medical Degree
Medical Academy of Warsaw, Warsaw, Poland

Doctorate
Polish Academy of Sciences, Warsaw, Poland

Instructor
Department of Pharmacodynamics, The Institute of Physiology, Warsaw, Poland

Research Information

In vitro model of cleanup after a hemorrhagic stroke. Microglia (brain macrophages) scavenge red blood cells to and from the culture media. Video courtesy from the lab of Jarek Aronowski, MD, PhD.